Alabama Litigation Review

Alabama Litigation Review

Insights & Commentary on Developments in Alabama Litigation

Tag Archives: FDA

Does The Drug Abilify Cause Compulsive Behaviors?

Posted in Defective Products
It’s difficult to believe. Like many people, I had serious doubts. Very serious doubts. Can a drug really cause compulsive behaviors like uncontrollable gambling? Many Abilify victims suffered the doubts of family and friends. Yet, new medical research now supports a link between the drug and these dangerous compulsive behaviors. WHAT IS ABILIFY? The Food… Continue Reading

New Anticoagulants Continue To Raise Safety Issues

Posted in Defective Products, Personal Injury
In September, I discussed new anticoagulants Xarelto and Eliquis. My prior post concludes by noting patients deserve drugs approved only after careful study for safety. Shortly after that post, the ISMP Quarterwatch also raised issues concerning the safety of new anticoagulants rivaroxaban (Xarelto), dabigatron (Pradaxa), and apixaban (Eliquis). According to Quarterwatch: The adverse event reports for oral… Continue Reading

Invokana And The Risk Of Bone Fractures

Posted in Defective Products
Is Invokana (canagliflozin) a dangerous and defective drug? In a prior post, I discussed the history of Invokana and its link to ketoacidosis. Ketoacidosis can be a life-threatening condition caused by a build-up of acid in the blood. Now, the FDA has issued a new Invokana safety warning. According to the new FDA safety alert:… Continue Reading

First Pradaxa. Then Xarelto. Now Eliquis?

Posted in Defective Products, Personal Injury
Will Eliquis join Pradaxa and Xarelto as another anti-coagulant drug facing claims of severe internal bleeding? Pradaxa was the first of these three new anti-coagulants (blood thinners). It hit the market in 2010. Sales quickly boomed. However, adverse reports of severe internal hemorrhaging and bleeding soon followed. In May 2014, Pradaxa’s manufacturer settled about 4,000… Continue Reading

Invokana – Is The Drug A Safe Treatment For Diabetes?

Posted in Defective Products, Personal Injury
Invokana (canagliflozin) is a relatively new drug marketed to treat Type 2 diabetes. The drug is the first in a new class of medications known as sodium-glucose cotransporter 2 (SGLT2) inhibitors. This class of drugs also includes Farxiga, Glyxambi, Jardiance, and Xigduo XR. How does this new class of drugs work? The drugs work by altering… Continue Reading

Were Clinical Trials For Xarelto Tainted By Misconduct?

Posted in Defective Products, Personal Injury
What is Xarelto? Xarelto (Rivaroxaban) is a relatively new anticoagulant (blood thinner). The FDA first approved Xarelto in 2011. It is distributed in the United States by Johnson & Johnson subsidiary Janssen Pharmaceuticals and Bayer Healthcare. Xarelto was released as a replacement for Coumadin (Warfarin), a blood thinner effectively used for decades. Xarelto is used… Continue Reading

Failed FDA Process Opens Door To Dangerous Medical Devices

Posted in Defective Products, Personal Injury
Power morcellators. Transvaginal mesh. Both are examples of the FDA’s faulty 510(k) process. I’ve written several times about transvaginal mesh – products that have caused tremendous personal injury to women in Alabama and throughout the United States. Last week, I sat through the deposition of our expert witness in one mesh case. This medical specialist… Continue Reading

Update: Injured By A Defective Generic Drug? Where Is The Justice?

Posted in Defective Products
In August, I wrote about the recent Supreme Court decisions shielding generic drug makers from accountability for injuries and deaths caused by their defective drugs. Because generic drug makers were required to use the same warning label as the brand name manufacturer, they were provided immunity for failing to warn of dangerous side effects. This… Continue Reading

Defective Drugs And Research Bias

Posted in Defective Products
We are presently representing clients who have been injured by several different defective medical products, including the diabetes drug Actos and transvaginal mesh. As part of our work, we have studied much of the available medical research. Recently, I viewed an interesting discussion on an issue important in the medical research. The issue is: Why are… Continue Reading

Depuy Hip Replacement Implants and the Influence of Medical Device Manufacturers over Physicians

Posted in Defective Products
Last month I discussed the recent recall of the ASR hip replacement products manufactured by Depuy Orthopedics.  With over 90,000 of these medical implants sold, this is a tremendous issue that will affect many people.  These defective implants can result in significant injuries and damages to the individuals using them.  How will Depuy treat the patients who underwent these… Continue Reading